Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.

BACKGROUND Biofilms affect >80% bacterial infections in human and are usually difficult to eradicate because of their inherent drug resistance. METHODS We investigated the effectiveness of antimicrobial blue light (aBL) (wavelength, 415 nm) for inactivating Acinetobacter baumannii or Pseudomonas aeruginosa biofilms in 96-well microplates or infected mouse burn wounds. RESULTS In vitro, in 96-well microplates, exposure of 24-hour-old and 72-hour-old A. baumannii biofilms to 432 J/cm(2) aBL resulted in inactivation of 3.59 log10 and 3.18 log10 colony-forming units (CFU), respectively. For P. aeruginosa biofilms, similar levels of inactivation-3.02 log10 and 3.12 log10 CFU, respectively-were achieved. In mouse burn wounds infected with 5 × 10(6) CFU ofA. baumannii, approximately 360 J/cm(2) and 540 J/cm(2) aBL was required to inactivate 3 log10 CFU in biofilms when delivered 24 and 48 hours, respectively, after bacterial inoculation. High-performance liquid chromatography analysis revealed the presence of endogenous porphyrins in both A. baumannii and P. aeruginosa TUNEL assay detected no apoptotic cells in aBL-irradiated mouse skin at up to 24 hours after aBL exposure (540 J/cm(2)). CONCLUSIONS aBL has antimicrobial activity in biofilms ofA. baumannii and P. aeruginosa and is a potential therapeutic approach for biofilm-related infections.

[1]  R. Sommer,et al.  New approaches to control infections: anti-biofilm strategies against gram-negative bacteria. , 2013, Chimia.

[2]  I. Olsen,et al.  Biofilm-specific antibiotic tolerance and resistance , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  A. Weintrob,et al.  Biofilms and persistent wound infections in United States military trauma patients: a case–control analysis , 2014, BMC Infectious Diseases.

[4]  Michael R Hamblin,et al.  Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections. , 2014, The Journal of infectious diseases.

[5]  U. Römling,et al.  Biofilm infections, their resilience to therapy and innovative treatment strategies , 2012, Journal of internal medicine.

[6]  M. Maciá,et al.  Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm Treatment , 2011, Antimicrobial Agents and Chemotherapy.

[7]  Søren Molin,et al.  Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms , 2003, Molecular microbiology.

[8]  A. Hamood,et al.  The ability of quaternary ammonium groups attached to a urethane bandage to inhibit bacterial attachment and biofilm formation in a mouse wound model , 2017, International wound journal.

[9]  Tianhong Dai,et al.  Blue Light Rescues Mice from Potentially Fatal Pseudomonas aeruginosa Burn Infection: Efficacy, Safety, and Mechanism of Action , 2012, Antimicrobial Agents and Chemotherapy.

[10]  M. Gilmore,et al.  Simplified agar plate method for quantifying viable bacteria. , 1997, BioTechniques.

[11]  Tianhong Dai,et al.  Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[12]  Tom Coenye,et al.  In vitro and in vivo model systems to study microbial biofilm formation. , 2010, Journal of microbiological methods.

[13]  K. Hiller,et al.  Blue light kills Aggregatibacter actinomycetemcomitans due to its endogenous photosensitizers , 2013, Clinical Oral Investigations.

[14]  K. Lewis Persister cells: molecular mechanisms related to antibiotic tolerance. , 2012, Handbook of experimental pharmacology.

[15]  H. Ceri,et al.  The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms , 1999, Journal of Clinical Microbiology.

[16]  Cary L. Honnold,et al.  Validation of a Novel Murine Wound Model of Acinetobacter baumannii Infection , 2013, Antimicrobial Agents and Chemotherapy.

[17]  Scott J. MacGregor,et al.  Inactivation of Bacterial Pathogens following Exposure to Light from a 405-Nanometer Light-Emitting Diode Array , 2009, Applied and Environmental Microbiology.

[18]  S. Molin,et al.  Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. , 2005, Microbiology.

[19]  G. Pugliese,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Infection Control & Hospital Epidemiology.

[20]  Joshua Dunham,et al.  Phototargeting Oral Black-Pigmented Bacteria , 2005, Antimicrobial Agents and Chemotherapy.

[21]  Tianhong Dai,et al.  Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. , 2013, Photomedicine and laser surgery.

[22]  S. Molin,et al.  Sublethal Ciprofloxacin Treatment Leads to Rapid Development of High-Level Ciprofloxacin Resistance during Long-Term Experimental Evolution of Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.

[23]  Atosa Ahmadi,et al.  Helicobacter pylori Accumulates Photoactive Porphyrins and Is Killed by Visible Light , 2005, Antimicrobial Agents and Chemotherapy.

[24]  Wills,et al.  In vitro studies of the effect of antiseptic‐containing mouthwashes on the formation and viability of Streptococcus sanguis biofilms , 1998, Journal of applied microbiology.

[25]  J. Haldar,et al.  Amide side chain amphiphilic polymers disrupt surface established bacterial bio-films and protect mice from chronic Acinetobacter baumannii infection. , 2016, Biomaterials.

[26]  Touqir Zahra,et al.  Optical monitoring and treatment of potentially lethal wound infections in vivo. , 2003, Journal of Infectious Diseases.

[27]  Thomas Bjarnsholt,et al.  Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. , 2010, FEMS immunology and medical microbiology.

[28]  Nikolaos S. Soukos,et al.  The effect of blue light on periodontal biofilm growth in vitro , 2015, Lasers in Medical Science.

[29]  Michael R Hamblin,et al.  Photodynamic Therapy for Acinetobacter baumannii Burn Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[30]  Matjaz Humar,et al.  Biocompatible optical needle array for antibacterial blue light therapy , 2015, Photonics West - Biomedical Optics.

[31]  K. Hiller,et al.  Photodynamic biofilm inactivation by SAPYR--an exclusive singlet oxygen photosensitizer. , 2013, Free radical biology & medicine.

[32]  I. Olsen,et al.  Bacterial sex in dental plaque , 2013, Journal of oral microbiology.

[33]  Garth D. Ehrlich,et al.  Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms , 2004, Antimicrobial Agents and Chemotherapy.

[34]  Mark E Meyerhoff,et al.  Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model. , 2014, Acta biomaterialia.

[35]  L. Durham,et al.  The occurrence and roles of porphyrins in the environment: possible implications for bioremediation , 1993 .

[36]  Chukuka S Enwemeka,et al.  Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro. , 2009, Photomedicine and laser surgery.

[37]  David Yens,et al.  Visible 405 nm SLD light photo‐destroys methicillin‐resistant Staphylococcus aureus (MRSA) in vitro , 2008, Lasers in surgery and medicine.

[38]  A. Oliver,et al.  ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  R. Gurny,et al.  Effects on Gram-Negative and Gram-Positive Bacteria Mediated by 5-Aminolevulinic Acid and 5-Aminolevulinic Acid Derivatives , 2008, Antimicrobial Agents and Chemotherapy.

[40]  David Lebeaux,et al.  Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics , 2014, Microbiology and Molecular Reviews.

[41]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[42]  Gerd Plewig,et al.  High-performance liquid chromatography analysis of porphyrins in Propionibacterium acnes , 2000, Archives of Dermatological Research.

[43]  S. Macgregor,et al.  Photoinactivation of Bacteria Attached to Glass and Acrylic Surfaces by 405 nm Light: Potential Application for Biofilm Decontamination , 2013, Photochemistry and photobiology.

[44]  Philip S. Stewart,et al.  Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.

[45]  S. Macgregor,et al.  Effect of 405-nm high-intensity narrow-spectrum light on fibroblast-populated collagen lattices: an in vitro model of wound healing. , 2011, Journal of biomedical optics.